Annual Drug Patent Expirations for STRIBILD Stribild is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent expiration for Gilead Sciences drug STRIBILD appeared …
New patent expiration for Gilead Sciences drug STRIBILD Read Post »
Annual Drug Patent Expirations for ODEFSEY Odefsey is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Gilead Sciences drug ODEFSEY appeared first on…
New patent expiration for Gilead Sciences drug ODEFSEY Read Post »
Annual Drug Patent Expirations for GENVOYA Genvoya is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are thirteen…
The post New patent expiration for Gilead Sciences drug GENVOYA appeared fi…
New patent expiration for Gilead Sciences drug GENVOYA Read Post »
Annual Drug Patent Expirations for DESCOVY Descovy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from two suppliers. There are six…
The post New patent expiration for Gilead Sciences drug DESCOVY appeared first o…
New patent expiration for Gilead Sciences drug DESCOVY Read Post »
Annual Drug Patent Expirations for COMPLERA Complera is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are twelve…
The post New patent expiration for Gilead Sciences drug COMPLERA appeared fi…
New patent expiration for Gilead Sciences drug COMPLERA Read Post »
Annual Drug Patent Expirations for ATRIPLA Atripla is a drug marketed by Gilead Sciences and is included in one NDA. It is available from two suppliers. There are nine patents…
The post New patent expiration for Gilead Sciences drug ATRIPLA appeared fi…
New patent expiration for Gilead Sciences drug ATRIPLA Read Post »
Annual Drug Patent Expirations for VYONDYS+53 Vyondys 53 is a drug marketed by Sarepta Theraps Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Sarepta Theraps drug VYONDYS 53 appeared fir…
New patent expiration for Sarepta Theraps drug VYONDYS 53 Read Post »
Annual Drug Patent Expirations for EXONDYS+51 Exondys 51 is a drug marketed by Sarepta Theraps Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Sarepta Theraps drug EXONDYS 51 appeared fir…
New patent expiration for Sarepta Theraps drug EXONDYS 51 Read Post »
Annual Drug Patent Expirations for AMONDYS+45 Amondys 45 is a drug marketed by Sarepta Theraps Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Sarepta Theraps drug AMONDYS 45 appeared fir…
New patent expiration for Sarepta Theraps drug AMONDYS 45 Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Norway. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceutical …
Which pharmaceutical companies have the most SPCs in Norway? Read Post »
Get new actionable insights and updates from BiotechBlog
